Chemokines take centre stage in vascular biology

Christian Weber

doi:10.1160/TH07-02-0112

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2007; 97(05): 685-687
DOI: 10.1160/TH07-02-0112

Theme Issue Editorial Focus

Schattauer GmbH

Chemokines take centre stage in vascular biology

Christian Weber

¹Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Murphy PM, Baggiolini M, Charo IF. et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52: 145-176.
2 Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 02: 108-115.
3 Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891-928.
4 Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-621.
5 Moser B, Wolf M, Walz A. et al. Chemokines: multiple levels of leukocyte migration control. Trends Immunol 2004; 25: 75-84.
6 Weber C, Koenen RR. Fine-tuning leukocyte responses: towards a chemokine 'interactome'. Trends Immunol 2006; 27: 268-273.
7 Weber C, Schober A, Zernecke A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 1997-2008.
8 Schober A, Karshovska E, Zernecke A. et al. SDF- 1 α -mediated tissue repair by stem cells: a promising tool in cardiovascular medicine?. Trends Cardiovasc Med 2006; 16: 103-108.
9 Colditz IG, Schneider MA, Prünster M. et al. Chemokines at large: in vivo mechanisms of their transport, presentation and clearance. Thromb Haemost 2007; 97: 688-693.
10 Ludwig A, Weber C. Transmembrane chemokines: Versatile 'special agents' in vascular inflammation. Thromb Haemost 2007; 97: 694-703.
11 von Hundelshausen P, Petersen F, Brandt E. Platelet- derived chemokines in vascular biology. Thromb Haemost 2007; 97: 704-713.
12 Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
13 Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007; 97: 714-721.
14 Tacke F, Alvarez D, Kaplan TJ. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007; 117: 185-194.
15 Weber C, Belge KU, von Hundelshausen P. et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 2000; 67: 699-704.
16 Lambert MP, Sachais BS, Kowalska MA. Chemokines and thrombogenecity. Thromb Haemost 2007; 97: 722-729.
17 Schober A, Zernecke A. Chemokines in vascular remodelling. Thromb Haemost 2007; 97: 730-737.
18 Frangogiannis N. Chemokines in ischemia/reperfusion injury. Thromb Haemost 2007; 97: 738-747.
19 Aukrust P, Yndestad A, Smith C. et al. Chemokines in cardiovascular risk prediction. Thromb Haemost 2007; 97: 748-754.
20 Mehrad B, Keane M, Strieter RM. Chemokines as mediators in angiogenesis. Thromb Haemost 2007; 97: 755-762.
21 Heil M, Eitenmuller I, Schmitz-Rixen T. et al. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 2006; 10: 45-55.
22 Ebenebe CU, Diehl S, Bartnick K. et al. Three reactive compartments in venous malformations. Thromb Haemost 2007; 97: 763-773.
23 Yang D, Chertov O, Bykovskaia SN. et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286: 525-528.
24 Bernhagen J, Krohn R, Lue H. et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Med. 2007 doi:10.1038/n